newest glp 1 agonist A Comprehensive Review of the Role of GLP-1 Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure “Weighing In” on GLP-1 Receptor
Description
Researchers who are sensitive to gastrointestinal side effects or who have experienced significant issues with semaglutide constipation or tirzepatide GI issues may find cagrilintide monotherapy more tolerable, even at the cost of somewhat lower weight loss
Rise of Dual and Triple Agonists: Beyond GLP-1, newer drugs target GIP and glucagon receptors for enhanced efficacy (e.g., Tirzepatide, Retatrutide)
This hypothesized mechanism could enhance insulin secretion and suppress glucagon secretion in glucose-dependent manners (Figure 1)
These findings are significant to people with Alzheimers and Parkinsons
